Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 22, 2012, Pages 8546-8551

  Deleault, Nathan R ^a   Piro, Justin R ^a   Walsh, Daniel J ^a   Wang, Fei ^b   Jiyan, Ma ^b   Geoghegan, James C ^a,c   Supattapone, Surachai ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

PrP; Scrapie

Indexed keywords

PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPASE; PLASMALOGEN; PRION PROTEIN; RECOMBINANT PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; HAMSTER; IN VITRO STUDY; ISOLATION PROCEDURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PURIFICATION; SCRAPIE;

ANIMALS; BLOTTING, WESTERN; BRAIN; CRICETINAE; IMMUNOHISTOCHEMISTRY; MICE; NUCLEIC ACIDS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLGLYCEROLS; PHOSPHATIDYLINOSITOLS; PHOSPHATIDYLSERINES; PRIONS; PROTEIN FOLDING; RECOMBINANT PROTEINS; RNA;

ANIMALIA; CRICETINAE; MAMMALIAN PRION;

EID: 84861848298     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1204498109     Document Type: Article

References (26)

1. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
2. Supattapone S (2010) Biochemistry. What makes a prion infectious? Science 327:1091-1092.
3. Caughey B, Baron GS (2006) Prions and their partners in crime. Nature 443:803-810. (Pubitemid 44622685)
4. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104:9741-9746. (Pubitemid 47175337)
5. Wang F, Wang X, Yuan CG, Ma J (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132-1135.
6. Wang F, et al. (2012) Genetic informational RNA is not required for recombinant prion infectivity. J Virol 86:1874-1876.
7. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S (2010) Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49:3928-3934.
8. Kazlauskaite J, Sanghera N, Sylvester I, Vénien-Bryan C, Pinheiro TJ (2003) Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42:3295-3304. (Pubitemid 36348638)
9. Wang F, et al. (2007) Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry 46:7045-7053. (Pubitemid 46906433)
10. Deleault NR, Lucassen RW, Supattapone S (2003) RNA molecules stimulate prion protein conversion. Nature 425:717-720. (Pubitemid 37314314)
11. Gonzalez-Montalban N, Makarava N, Savtchenko R, Baskakov IV (2011) Relationship between conformational stability and amplification efficiency of prions. Biochemistry 50:7933-7940.
12. Thorne L, Terry LA (2008) In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89:3177-3184.
13. Kim JI, et al. (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285:14083-14087.
14. Gabizon R, McKinley MP, Groth DF, Kenaga L, Prusiner SB (1988) Properties of scrapie prion protein liposomes. J Biol Chem 263:4950-4955.
15. Müller H, Stitz L, Wille H, Prusiner SB, Riesner D (2007) Influence of water, fat, and glycerol on the mechanism of thermal prion inactivation. J Biol Chem 282:35855-35867. (Pubitemid 350277108)
16. Hunter GD, Kimberlin RH, Millson GC, Gibbons RA (1971) An experimental examination of the scrapie agent in cell membrane mixtures. I. Stability and physicochemical properties of the scrapie agent. J Comp Pathol 81:23-32.
17. Taylor DM, Fernie K, McConnell I, Ferguson CE, Steele PJ (1998) Solvent extraction as an adjunct to rendering: The effect on BSE and scrapie agents of hot solvents followed by dry heat and steam. Vet Rec 143:6-9. (Pubitemid 128494638)
18. Gale P (2006) The infectivity of transmissible spongiform encephalopathy agent at low doses: The importance of phospholipid. J Appl Microbiol 101:261-274.
19. Gale P (2007) The prion/lipid hypothesis - further evidence to support the molecular basis for transmissible spongiform encephalopathy risk assessment. J Appl Microbiol 103:2033-2045.
20. Alper T, Cramp WA, Haig DA, Clarke MC (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214:764-766.
21. Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930-936. (Pubitemid 350098981)
22. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470:540-542.
23. Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70:532-540.
24. Nishina KA, Supattapone S (2007) Immunodetection of glycophosphatidylinositol-anchored proteins following treatment with phospholipase C. Anal Biochem 363:318-320. (Pubitemid 46428218)
25. Piro JR, et al. (2009) Prion protein glycosylation is not required for strain-specific neurotropism. J Virol 83:5321-5328.
26. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354. (Pubitemid 9256559)